DJSG
PPH icon

D.J. St. Germain’s VanEck Pharmaceutical ETF PPH Stock Holding History

D.J. St. Germain’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-50
Closed -$4.75K – 859
2024
Q3 		$4.75K Hold
50
– – ﹤0.01% 615
2024
Q2 		$4.57K Hold
50
– – ﹤0.01% 626
2024
Q1 		$4.54K Hold
50
– – ﹤0.01% 624
2023
Q4 		$4.07K Hold
50
– – ﹤0.01% 633
2023
Q3 		$3.99K Buy
+50
New +$4.03K ﹤0.01% 610

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
MTWSIF
Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

D.J. St. Germain's PPH Position: Q4 2024 in Review

D.J. St. Germain sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2024, closing a stake of 50 shares — an estimated $4.75K sold.

D.J. St. Germain first reported a position in PPH in Q3 2023 and held it in 5 quarters. The position peaked at $4.75K in Q3 2024. 142 funds tracked by Wall St. Rank hold PPH as of Q4 2024.

  • D.J. St. Germain reported no remaining VanEck Pharmaceutical ETF position as of Q4 2024 after selling out during the quarter.
  • D.J. St. Germain sold 50 VanEck Pharmaceutical ETF shares in Q4 2024, an estimated $4.75K.
  • D.J. St. Germain first reported a position in VanEck Pharmaceutical ETF in Q3 2023 and held it in 5 quarters.
  • D.J. St. Germain's VanEck Pharmaceutical ETF position peaked at $4.75K in Q3 2024.
  • 142 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2024.

Based on D.J. St. Germain's 13F filing for Q4 2024, filed 10 Jan 2025.